The bill amends various sections of Florida Statutes to enhance the regulation of drugs, vaccines, and cosmetics. It revises the definition of "drug" to include food containing a vaccine or vaccine material and introduces a new definition for "vaccine or vaccine material." The legislation establishes that a drug will be considered misbranded if it is a food containing a vaccine without proper labeling. Additionally, it requires cosmetics sold in Florida to provide public notice of certain added ingredients on a manufacturer-maintained website and prohibits the sale of cosmetics that release formaldehyde unless it is a natural byproduct with no functional purpose. The bill also defines "messenger ribonucleic acid vaccine" (mRNA vaccine) and prohibits the use of fruits and vegetables as delivery mechanisms for mRNA vaccines.

Furthermore, the bill introduces new provisions for restricted prescription drug distributors, specifying that applicants must provide information as required under section 499.012 and allowing the Department of Business and Professional Regulation to establish rules for the distribution of prescription drugs by various entities. It clarifies that a restricted prescription drug distributor permit is not necessary for certain distributions between pharmacies under common ownership in specific circumstances. The bill updates legal references, revises recordkeeping and handling requirements for prescription drug distributions, and aims to streamline the regulatory framework while maintaining public health safeguards. The act is set to take effect on July 1, 2025.